Budesonide and fluticasone and adrenal suppression
Main Authors: | Mona A Fouda, Feisal A Al-Kassimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Annals of Thoracic Medicine |
Online Access: | http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2012;volume=7;issue=4;spage=253;epage=253;aulast=Fouda |
Similar Items
-
Efficacy of intranasal fluticasone propionate and budesonide in management of allergic rhinitis—a prospective comparative study
by: P. Kiruba Shankari, et al.
Published: (2021-11-01) -
Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety
by: Samy Suissa, et al.
Published: (2022-12-01) -
The Effectiveness and Safety of Ciclesonide versus Fluticasone, Budesonide, and Beclomethasone in Treatment of Persistent Asthma: A Comprehensive Review of Literature
by: Zahra Zali, et al.
Published: (2014-05-01) -
Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
by: Iseul Yu, et al.
Published: (2022-07-01) -
Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
by: Perrone V, et al.
Published: (2016-11-01)